# Preoperative Octreotide Treatment of Acromegaly

> **NCT00521300** · PHASE4 · COMPLETED · sponsor: **St. Olavs Hospital** · enrollment: 62 (actual)

## Conditions studied

- Acromegaly

## Interventions

- **DRUG:** Octreotide
- **PROCEDURE:** Direct surgery for acromegaly

## Key facts

- **NCT ID:** NCT00521300
- **Lead sponsor:** St. Olavs Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-09
- **Primary completion:** 2005-06
- **Final completion:** 2010-05
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2014-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00521300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00521300, "Preoperative Octreotide Treatment of Acromegaly". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00521300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*